Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Apr:18:94-108.
doi: 10.1016/j.ebiom.2017.03.009. Epub 2017 Mar 9.

Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis

Meng Zhang et al. EBioMedicine. 2017 Apr.

Abstract

Polymorphisms in X-ray repair cross-complementing (XRCC) genes have been implicated in altering the risk of various urological cancers. However, the results of reported studies are controversial. To ascertain whether polymorphisms in XRCC genes are associated with the risk of urological neoplasms, we conducted present updated meta-analysis and systematic review. Summary odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to estimate the association. Finally, 54 publications comprising 129 case-control studies for twelve polymorphisms in five XRCC genes were enrolled. We identified that XRCC1-rs25489 polymorphism was associated with an increased risk of urological neoplasms in heterozygote and dominant models. Moreover, in the subgroup analysis by cancer type, we found that XRCC1-rs25489 polymorphism was associated with an increased risk of bladder cancer (BC) in heterozygote model. Although overall analyses suggested a null result for XRCC1-rs25487 polymorphism, in the stratified analysis by ethnicity, an increased risk of urological neoplasms for Asians in allelic and homozygote models was identified. While for other polymorphisms in XRCC genes, no significant association was uncovered. To sum up, our results indicated that XRCC1-rs25489 polymorphism is a risk factor for urological neoplasms, particularly for BC. Further studies with large sample size are needed to validate these findings.

Keywords: Meta-analysis; Polymorphism; Risk; Urological neoplasm; XRCC.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plots of the association between XRCC1-rs25489 polymorphism and the risk of urological neoplasms (BA vs. AA). Each square indicates a study, and the area of squares is proportional to the weight of the study. The diamond represents the summary OR and 95% CI. CI = confidence interval, OR = odds ratio.
Fig. 2
Fig. 2
Forest plots of the association between XRCC1-rs25487 polymorphism and the risk of urological neoplasms (B vs. A). Each square indicates a study, and the area of squares is proportional to the weight of the study. The diamond represents the summary OR and 95% CI. CI = confidence interval, OR = odds ratio.

Similar articles

Cited by

References

    1. Abe M., Xie W., Regan M.M., King I.B., Stampfer M.J., Kantoff P.W., Oh W.K., Chan J.M. Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer. BJU Int. 2011;107:126–134. - PMC - PubMed
    1. Agalliu I., Kwon E.M., Salinas C.A., Koopmeiners J.S., Ostrander E.A., Stanford J.L. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control. 2010;21:289–300. - PMC - PubMed
    1. Alli E., Sharma V.B., Sunderesakumar P., Ford J.M. Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009;69:3589–3596. - PMC - PubMed
    1. Andrew A.S., Gui J., Hu T., Wyszynski A., Marsit C.J., Kelsey K.T., Schned A.R., Tanyos S.A., Pendleton E.M., Ekstrom R.M. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. BJU Int. 2015;115:238–247. - PMC - PubMed
    1. Andrew A.S., Karagas M.R., Nelson H.H., Guarrera S., Polidoro S., Gamberini S., Sacerdote C., Moore J.H., Kelsey K.T., Demidenko E. DNA Repair Polymorphisms Modify Bladder Cancer Risk: A Multi-factor Analytic Strategy. Hum. Hered. 2007;65:105–118. - PMC - PubMed

Substances

LinkOut - more resources